Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relatives.

Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.

Expanded genetic screening panel for the Ashkenazi Jewish population.

Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.

Hereditary chondrocalcinosis in an Ashkenazi Jewish family.

Causes of death in patients with Huntington's disease and in unaffected first degree relatives.

2 testing in Ashkenazi Jewish individuals without founder mutations.

Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives.

Transitive inference deficits in unaffected biological relatives of schizophrenia patients.

Carrier screening of RTEL1 mutations in the Ashkenazi Jewish population.

Niemann-Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients.

Reticulin antibodies in patients with coeliac disease and their relatives.

Mutation analysis of an Ashkenazi Jewish family with Gaucher disease in three successive generations.

Erratum to: Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.

Parents' interest in genetic testing of their offspring in multiplex epilepsy families.

Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives.

Dissociation between affective experience and motivated behaviour in schizophrenia patients and their unaffected first-degree relatives and schizotypal individuals.

An unusual genotype in an Ashkenazi Jewish patient with Tay-Sachs disease.

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.

Executive function in probands with autism with average IQ and their unaffected first-degree relatives.

Attitudes of patients and their relatives to Huntington's disease.

GREM1 germline mutation screening in Ashkenazi Jewish patients with familial colorectal cancer.

Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.

Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience : Education and Barriers assessment for Jewish Genetic Diseases.

Suggest Documents

Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.

Expanded genetic screening panel for the Ashkenazi Jewish population.

Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.

Hereditary chondrocalcinosis in an Ashkenazi Jewish family.

Causes of death in patients with Huntington's disease and in unaffected first degree relatives.

2 testing in Ashkenazi Jewish individuals without founder mutations.

Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives.

Transitive inference deficits in unaffected biological relatives of schizophrenia patients.

Carrier screening of RTEL1 mutations in the Ashkenazi Jewish population.

Niemann-Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients.

Reticulin antibodies in patients with coeliac disease and their relatives.

Mutation analysis of an Ashkenazi Jewish family with Gaucher disease in three successive generations.

Erratum to: Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.

Parents' interest in genetic testing of their offspring in multiplex epilepsy families.

Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives.

Dissociation between affective experience and motivated behaviour in schizophrenia patients and their unaffected first-degree relatives and schizotypal individuals.

An unusual genotype in an Ashkenazi Jewish patient with Tay-Sachs disease.

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.

Executive function in probands with autism with average IQ and their unaffected first-degree relatives.

Attitudes of patients and their relatives to Huntington's disease.

GREM1 germline mutation screening in Ashkenazi Jewish patients with familial colorectal cancer.

Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.

Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience : Education and Barriers assessment for Jewish Genetic Diseases.

Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relatives.

Recommend Documents

Follow Us